Protect from moisture and light
Blue Shield of California formulary and drug coverage policies California Medi-Cal dropped GLP-1 obesity coverage effective January 1, 2026, joining several other states that reduced coverage amid rising drug costs
Batch specificity matters: scientific identifiers and analytical results should be taken from the documentation for the exact batch supplied
Participants were randomized to placebo or one of four Retatrutide dose groups (1mg, 4mg, 8mg, or 12mg weekly)
Last reviewed: July 14, 2026 Last updated: July 14, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
IMPORTANT: Upon order completion, an Order # will be generated